Xiaojiang Li

623 citations
22 papers · 466 indexed · h-index 12
Topics
RNA modifications and cancer (7 papers)Cancer-related molecular mechanisms research (6 papers)Cancer, Hypoxia, and Metabolism (3 papers)
Partner nations
ChinaUnited StatesGreece

In The Last Decade

Xiaojiang Li

22 papers receiving 459 citations

Peers

Xiaojiang Li
Comparison fields: 5 of 84
  • Molecular Biology 310
  • Cancer Research 179
  • Plant Science 72
  • Pulmonary and Respiratory Medicine 53
  • Oncology 41
Replace Wenbo Hao with:
Wenbo Hao China
Valentina A. Lakunina Russia
Beibei Lv China
Ao Liu China
Chantal Garand Canada
Malathi Banda United States
Yuyan Zhang China
Xiaoxue Li China
Shuo Han China
Xiaojiang Li relative to Wenbo Hao China Wenbo Hao's profile →
Citations per field
00.5×1.5×2.4×
Wenbo Hao · 1×
Citations per year

Countries citing papers authored by Xiaojiang Li

Since Specialization
Citations

This map shows the geographic impact of Xiaojiang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojiang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojiang Li more than expected).

Fields of papers citing papers by Xiaojiang Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaojiang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojiang Li. The network helps show where Xiaojiang Li may publish in the future.

Co-authorship network of co-authors of Xiaojiang Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaojiang Li. A scholar is included among the top collaborators of Xiaojiang Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaojiang Li. Xiaojiang Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 9
2 3
3 1
4 7
5 15
6 6
7 18
8 21
9 13
10 8
11 12
12 100
13 101
14 23
15 12
16 11
17 48
18 19
19 2
20
[Clinical study on cytokine induced killer cells therapy to laryngeal cancer after radiotherapy].
1

About Xiaojiang Li

Xiaojiang Li is a scholar working on Cancer Research, Behavioral Neuroscience and Molecular Biology, having authored 22 papers that have together received 466 indexed citations. Recurring topics across this work include RNA modifications and cancer (7 papers), Cancer-related molecular mechanisms research (6 papers) and Cancer, Hypoxia, and Metabolism (3 papers). The work is most often cited by research in Cancer Research (179 citations), Molecular Biology (310 citations) and Horticulture (3 citations). Xiaojiang Li has collaborated with scholars based in China, United States and Greece. Frequent co-authors include Yingjie Jia, Shanqi Guo, Xingkang Jiang, Yangyi Zhang, Baojie Ma, Fei Chen, Yong Xu, Yunfeng Song, Junhao Chen and Zhenguo Lin. Their work appears in journals such as Scientific Reports, Medicine and Toxicology and Applied Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026